FDA Drug Safety Communication: New Boxed Warning on severe liver injury with propylthiouracil
This is a discussion on FDA Drug Safety Communication: New Boxed Warning on severe liver injury with propylthiouracil within the FDA News forum, part of the Industry News and Updates category; The United States Food and Drug Administration (FDA) has added a Boxed Warning to the label for propylthiouracil, a drug ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
04-21-2010, 02:06 PM
|
|||
|
|||
FDA Drug Safety Communication: New Boxed Warning on severe liver injury with propylthiouracil
The United States Food and Drug Administration (FDA) has added a Boxed Warning to the label for propylthiouracil, a drug used to treat hyperthyroidism (overactive thyroid), to include information about reports of severe liver injury and acute liver failure, some of which have been fatal, in adult and pediatric patients using this medication.
More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| New Boxed Warning for Deferasirox | industry_news | Other Clinical Pharmacy News | 0 | 02-18-2010 09:13 PM |
| FDA Drug Safety Communication: Serious liver disorder associated with the use of Videx/Videx EC (didanosine) | industry_news | FDA News | 0 | 02-06-2010 07:38 AM |
| FDA Drug Safety Communication: Serious liver disorder associated with the use of Videx/Videx EC (didanosine) | industry_news | FDA News | 0 | 01-29-2010 02:36 PM |
| Recalls & Warnings Tysabri May Cause Significant Liver Injury Medscape Medical News, | industry_news | Other Clinical Pharmacy News | 0 | 02-28-2008 09:41 AM |
© 2008 DrugManagementForum™ powered by |
 |